Andy Bolden

Europe Media Director / Global Head of Trading, GlaxoSmithKline

rsz andy bolden

Andy's role is to manage the relationship between the Marketing teams and the media agencies, ensuring cost effective and whenever possible, innovative media connection activity to drive brand growth.

GlaxoSmithKline is a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. 

Andy joined GSK in April 2003 after 30 years in various full service and media agencie and now runs a team of seven, in market, media managers to deliver Best Practice Media Management across Europe. Andy represent GSK on the AVAG and Futures Group’s at ISBA.